Skip to main content

Table 3 Survival analyses of cancer-specific survival for extremity liposarcoma patients

From: Nomogram for predicting the overall survival and cancer-specific survival of patients with extremity liposarcoma: a population-based study

 

Univariate analysis

Multivariate analysis

P

HR

95.0% CI

P

Age

  < 65

Reference

Reference

   

 65–76

0.416

1.25

0.83–1.88

0.277

  > 76

< 0.001

3.26

2.19–4.85

< 0.001

Tumor size

  < 7.4

Reference

Reference

   

 7.4–12.4

0.036

2.42

1.43–4.10

0.001

  > 12.4

< 0.001

3.73

2.32–6.01

< 0.001

Race

 Black

Reference

    

 Other

0.609

    

 White

0.668

    

Sex

 Female

Reference

Reference

  

 Male

0.001

1.42

1.01–2.00

0.047

Histological type

 Liposarcoma, NOS

Reference

    

 Liposarcoma, well differentiated

< 0.001

    

 Myxoid liposarcoma

0.668

    

 Round cell liposarcoma

< 0.001

    

 Pleomorphic liposarcoma

< 0.001

    

 Mixed liposarcoma

0.024

    

 Fibroblastic liposarcoma

0.966

    

 Dedifferentiated liposarcoma

0.002

    

AJCC

 I/II

Reference

    

 III/IV

< 0.001

    

T

 T1

Reference

    

 T2

0.007

    

N

 N0

Reference

    

 N1

0.088

    

M

 M0

Reference

Reference

  

 M1

< 0.001

5.83

3.37–10.09

< 0.001

Surgery

 No

Reference

Reference

  

 Yes

< 0.001

0.43

0.21–0.85

0.015

Radiotherapy

 No

Reference

    

 Yes

< 0.001

    

Chemotherapy

 No

Reference

    

 Yes

< 0.001

    

Primary site

 Lower extremity

Reference

    

 Upper extremity

0.768

    

Grade

 I

Reference

Reference

   

 II

< 0.001

3.95

2.13–7.33

< 0.001

 III

< 0.001

14.10

8.34–23.85

< 0.001

 IV

< 0.001

19.02

11.41–31.71

< 0.001

  1. HR Hazard ratio, CI Confidence interval, AJCC American Joint Committee on Cancer
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us